AU2015317990B2 - Plant extracts for improving cognitive function - Google Patents

Plant extracts for improving cognitive function Download PDF

Info

Publication number
AU2015317990B2
AU2015317990B2 AU2015317990A AU2015317990A AU2015317990B2 AU 2015317990 B2 AU2015317990 B2 AU 2015317990B2 AU 2015317990 A AU2015317990 A AU 2015317990A AU 2015317990 A AU2015317990 A AU 2015317990A AU 2015317990 B2 AU2015317990 B2 AU 2015317990B2
Authority
AU
Australia
Prior art keywords
extract
day
cognitive
sleep
memory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015317990A
Other languages
English (en)
Other versions
AU2015317990A1 (en
Inventor
Michael Ceddia
Shulin Feng
Kelli HERRLINGER
Brandon LEWIS
Kristin Nieman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemin Industries Inc
Original Assignee
Kemin Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries Inc filed Critical Kemin Industries Inc
Publication of AU2015317990A1 publication Critical patent/AU2015317990A1/en
Application granted granted Critical
Publication of AU2015317990B2 publication Critical patent/AU2015317990B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2015317990A 2014-09-15 2015-09-15 Plant extracts for improving cognitive function Active AU2015317990B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462050563P 2014-09-15 2014-09-15
US62/050,563 2014-09-15
PCT/US2015/050230 WO2016044299A1 (en) 2014-09-15 2015-09-15 Plant extracts for improving cognitive function

Publications (2)

Publication Number Publication Date
AU2015317990A1 AU2015317990A1 (en) 2017-04-06
AU2015317990B2 true AU2015317990B2 (en) 2020-04-30

Family

ID=55453722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015317990A Active AU2015317990B2 (en) 2014-09-15 2015-09-15 Plant extracts for improving cognitive function

Country Status (8)

Country Link
US (2) US10857195B2 (https=)
EP (1) EP3194028A4 (https=)
JP (3) JP2017527591A (https=)
KR (2) KR20240000637A (https=)
AU (1) AU2015317990B2 (https=)
BR (1) BR112017005133A2 (https=)
CA (1) CA2961378A1 (https=)
WO (1) WO2016044299A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12213505B2 (en) 2021-07-05 2025-02-04 Healthy Ingredient Solutions, LLC Composition for promoting restful sleep and methods of making and using the same
CN116474049A (zh) * 2023-03-17 2023-07-25 深圳福图仁泰生物科技有限公司 一种兼具抗抑郁和促睡眠功效的植物天然水溶性复合物及其制备方法和应用
GB202402670D0 (en) * 2024-02-26 2024-04-10 Givaudan Sa Composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008090474A2 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
US20110151033A1 (en) * 2009-12-21 2011-06-23 Biotropics Malaysia Bhd Orthosiphon stamineus extracts for use as a cognition enhancer
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752476A (en) * 1986-02-18 1988-06-21 Copney Claudette V Sleep aiding herbal composition and method of utilizing same
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
JP2002275061A (ja) * 2001-03-19 2002-09-25 Tsumura & Co 抗うつ・抗不安剤
JP3947149B2 (ja) * 2002-10-28 2007-07-18 高砂香料工業株式会社 消臭剤組成物
CN1566300A (zh) * 2003-07-09 2005-01-19 新疆芳香植物科技开发股份有限公司 制造香囊、香枕的芳香组合物及其制备方法
JP2005053891A (ja) * 2003-07-18 2005-03-03 Seresu Corporation:Kk リパーゼ阻害剤
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
WO2008122099A1 (en) * 2007-04-05 2008-10-16 Iomedix Development International Srl Composition for promoting sleep and relaxation comprising lemon balm
ES2561330T3 (es) * 2007-10-17 2016-02-25 Rudolf Wild Gmbh & Co. Kg Composición que comprende extractos de toronjil
WO2009106121A1 (en) * 2008-02-25 2009-09-03 Nestec S.A. Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway
JP2010106001A (ja) 2008-10-31 2010-05-13 Theravalues Corp Ｐｐａｒ活性化剤
EP2398340A2 (en) * 2009-02-20 2011-12-28 DSM IP Assets B.V. Oregano extract for alertness
US9545076B2 (en) * 2011-02-08 2017-01-17 Kemin Industries, Inc. Spearmint plant denominated KI-MsEM0042
US9545075B2 (en) * 2011-02-08 2017-01-17 Kemin Industries, Inc. Spearmint plant denominated KI-MsEM0110
JP5668258B2 (ja) * 2011-10-21 2015-02-12 ザ マッキス カンパニー インコーポレイテッド エゴマの葉マッコリ及びその製造方法
US20140302170A1 (en) * 2013-04-08 2014-10-09 Scientific Nutrition Products, Inc. Compositions and methods for promoting sleep
JP2017507125A (ja) * 2014-01-30 2017-03-16 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 認知機能を向上させるための植物抽出物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008090474A2 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
US20110151033A1 (en) * 2009-12-21 2011-06-23 Biotropics Malaysia Bhd Orthosiphon stamineus extracts for use as a cognition enhancer
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FARR SA ET AL: ABSTRACTS OF THE ANNUAL MEETING OF THE SOCIETY FOR NEUROSCI, SOCIETY FOR NEUROSCIENCE, US vol. 43 9 November 2013 (2013-11-09), pages 1-2. *
Kristin Niemann ET AL: The FASEB Journal", FAS EB Journal, 1 April 2014 (2014-04-01) *

Also Published As

Publication number Publication date
US20160074459A1 (en) 2016-03-17
EP3194028A1 (en) 2017-07-26
JP2017527591A (ja) 2017-09-21
AU2015317990A1 (en) 2017-04-06
KR20170054501A (ko) 2017-05-17
KR20240000637A (ko) 2024-01-02
JP7818640B2 (ja) 2026-02-20
WO2016044299A1 (en) 2016-03-24
JP2024075715A (ja) 2024-06-04
EP3194028A4 (en) 2018-10-10
BR112017005133A2 (en) 2018-01-23
JP2022084873A (ja) 2022-06-07
CA2961378A1 (en) 2016-03-24
US20160166629A1 (en) 2016-06-16
US10857195B2 (en) 2020-12-08

Similar Documents

Publication Publication Date Title
JP7360267B2 (ja) 認知機能を向上させるための植物抽出物
JP7818640B2 (ja) 睡眠を改善するための植物抽出物
Sarris et al. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence
Lakhan et al. Nutritional therapies for mental disorders
Farokhnia et al. N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study
Seo et al. Effect of MIND diet on cognitive function in elderly: a narrative review with emphasis on bioactive food ingredients
Manzoor et al. A Comprehensive Review on Anxiolytic Effect of Lavandula Angustifolia Mill. in Clinical Studies
US12194071B2 (en) Methods and compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil providing anti-inflammatory effects and neuroprotection for disease states
JP2019520806A (ja) Ｌ−テアニン、プロアントシアニジン及びカテキンを含む組成物及びその使用
Mannaa et al. Efficacy of fish liver oil and propolis as neuroprotective agents in pilocarpine epileptic rats treated with valproate
US11357810B2 (en) Compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil having synergistic effects for improving memory, focus, and cognitive function, and related methods
Recart et al. Therapeutic approaches employing natural compounds and derivatives for treating bipolar disorder: emphasis on experimental models of the manic phase
Bongartz et al. Sleep Promoting Effects of IQP‐AO‐101: A Double‐Blind, Randomized, Placebo‐Controlled Exploratory Trial
Morgan et al. Outcomes of self-help efforts in anxiety disorders
Tarfarosh et al. Search for a perfect Nootropic supplement combination-Can we increase human intelligence by nutritional supplements
Kelly et al. Integrative Approaches to Cognitive Decline
Sethi et al. Nutritional Deficiencies in Obsessive-Compulsive Disorder and Possible Treatment Interventions
Urmi Natural products in cardiovascular disease treatment-a comprehensive review
Myers Ingredients for active aging
Marina et al. FOR A BETTER QUALITY OF LIFE IN ELDERLY.
Vitetta The effects of an extract of Pinus radiata pine bark (Enzogenol®) on cognitive function in individuals at risk of cognitive decline
Chen et al. Nutritional Approaches in Alzheimer's Disease Prevention
Diamond et al. COMPLEMENTARY, ALTERNATIVE, AND IN INTEGRATIVE THE TREATMENT MEDICINE AND MANAGEMENT OF DEMENTIA

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)